Creating a Legacy of Hope with RevitaLash® Cosmetics
Gayle Brinkenhoff Inaugural Symposium: Genome, Damage and Repair in Breast Cancer
VENTURA, Calif., Dec. 4, 2014 /PRNewswire/ -- On September 17, 2014 RevitaLash® Cosmetics and City of Hope, a leading cancer research and treatment center, launched the inaugural Gayle Brinkenhoff Symposium in an effort to further support and establish a forum devoted to a better understanding of BRCA-related breast cancer. This symposium, hosted at the City of Hope campus in Duarte, California, featured a dynamic team of leading experts from influential cancer research and treatment centers throughout the country.
BRCA is a simple acronym for a complex cellular process, with life changing implications. The BRCA1 and BRCA2 gene mutations occur in one of the critical DNA repair pathways of human cells. These mutations, which are passed down through families, significantly increase the risk of developing breast and ovarian cancer in their recipients. The Gayle Brinkenhoff Symposium is envisioned as a pivotal opportunity for research scientists to share their latest findings with one another, to collaborate with other health care professionals, and to discuss concepts for future research possibilities. Through this cooperative process, new ideas and eventual breakthroughs can evolve.
As a proud underwriter of the Gayle Brinkenhoff Symposium Series, RevitaLash® Cosmetics continues to demonstrate its unwavering dedication to learning more about this disease, with the goal of ultimately finding a cure. Motivated by his courageous wife, Gayle, who was diagnosed with metastatic breast cancer at the age of 32, Dr. Michael Brinkenhoff, the founder of the company, developed the groundbreaking cosmetics brand: RevitaLash®. Through continued support of cancer research and educational initiatives, RevitaLash® Cosmetics is able to continue carrying on her legacy.
"My wife Gayle spent over a decade fighting metastatic breast cancer before she discovered the underlying reason for her disease was a BRCA mutation," explained Dr. Brinkenhoff, founder of RevitaLash® Cosmetics. "Our family's greatest hope is that this symposium will be a valuable tool to better understand and treat this disease, and will serve as a memorial to someone who exemplified courage, compassion and grace throughout her life."
The day-long conference was devoted to scientific breakthroughs in all areas of genetic-related breast cancer research and care. Doctors and scientists from some of the country's most prestigious research institutions covered the complex issues involved in gene damage and repair in breast cancer, including advances in molecular oncology, new targets in DNA repair, personalized breast cancer therapy, risk assessment screening tools and registries, and the ethical and legal complexities of genetic testing.
The knowledge gained and shared between researchers will ultimately benefit patients. Through its sponsorship of this and future symposiums, RevitaLash® Cosmetics and City of Hope stand at the forefront of a new era of cancer genetics research, helping to empower families who carry BRCA1/2 gene mutations and save lives.
For more information on RevitaLash Cosmetics please contact Amanda Harris of Behrman Communications at 212-986-7000 or [email protected].
About RevitaLash® Cosmetics
Manufactured by Athena Cosmetics, Inc., the RevitaLash brand is a pioneer and worldwide leader in developing advanced lash, brow and hair beautification products. Established in 2006, the family of products which includes RevitaLash® Advanced, Nouriche®, RevitaBrow® Advanced, RevitaLash® Volumizing Mascara, RevitaLash® Volumizing Primer, RevitaLash® Fine Line Primer, RevitaLash® Spotlight Highlighting Pencil, and RevitaLash Raven 12 Hour Eyeliner can be found in over 10,000 physician's offices, premium spas, salons, and specialty retailers across the country and in over 40 countries worldwide. A devout supporter of non-profit breast cancer initiatives, Athena Cosmetics proudly donates a portion of sales proceeds to research and education initiatives, giving back to the community from which it was born. For information about the product line, visit www.revitalash.com. [RevitaLash Advanced is not available in California.]
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on facebook, twitter, youtube or flickr.
Photo - http://photos.prnewswire.com/prnh/20141203/162197
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/creating-a-legacy-of-hope-with-revitalash-cosmetics-300004519.html
SOURCE RevitaLash Cosmetics
Share this article